Category: AIDS, HIV & STDs
Global AIDS, HIV & STDs
-
Cephalosporin Market Report by Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation), Route of Administration (Injection, Oral), Application (Respiratory Tract, Skin Infection, Ear Infection, Urinary Tract Infection, Sexually Transmitted Infection, and Others), and Region 2025-2033
... market is experiencing steady growth driven by increasing antibiotic-resistant infections, the demand for effective and safer treatment options, ongoing research and development efforts to introduce new cephalosporin formulations, and rising awareness among healthcare professionals regarding ... Read More
-
STD Testing
... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia Testing, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis ... Read More
-
Kaposi Sarcoma
... CAGR of 3.2% over the analysis period 2024-2030. HAART, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$101.5 Million by the end of the analysis period. ... Read More
-
Infectious Disease Diagnostics
... at a CAGR of 5.5% over the analysis period 2024-2030. Diagnostic Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion by the ... Read More
-
Herpes Marker Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More
-
Global Syphilis Rapid Test Kit Competitive Landscape Professional Research Report 2025
... causes syphilis. This kit typically contains all the necessary components for conducting a simple and quick test, including test cassettes, sample collection swabs or lancets, buffer solutions, and instructions for use. The test works by ... Read More
-
Syphilis Testing Market by Type (Primary and Secondary Syphilis, Latent and Tertiary Syphilis), Location of Testing (Laboratory Testing, Point-of-Care (POC) Testing), and Region 2025-2033
... 2024. Looking forward, IMARC Group expects the market to reach USD 2.0 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The growing prevalence of sexually transmitted diseases (STDs), the increasing incidences ... Read More
-
Global Syphilis Immunoassay Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Syphilis is a sexually transmitted disease caused by a bacterium called treponema pallidum. ... Read More
-
Global Syphilis Immunoassay Diagnostics Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Syphilis Immunoassay Diagnostics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Syphilis Diagnosis Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Syphilis is a chronic, systemic sexually transmitted disease caused by the leptospira. The global pharmaceutical ... Read More
-
Global Syphilis Diagnosis Market Growth (Status and Outlook) 2024-2030
... market, the Syphilis Diagnosis is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Syphilis Diagnosis ... Read More
-
Global Syphilis Testing Market Growth (Status and Outlook) 2024-2030
... market, the Syphilis Testing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Syphilis Testing ... Read More
-
Global Neurosyphilis Market Growth (Status and Outlook) 2024-2030
... Neurosyphilis is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Neurosyphilis market. Neurosyphilis are expected ... Read More
-
Gene Therapy Market by Therapeutic Area (Cardiovascular Disorders, Dermatological Disorders, Genetic Disorders, Hematological Disorders, Metabolic Disorders, Muscle Disorders, Oncological Disorders, Ophthalmic Disorders and Other Disorders), Type of Vector (Adeno-associated Virus Vectors, Adenovirus Vectors, Herpes Simplex Virus Vectors, Lentivirus Vectors, Non-viral Vectors, Retrovirus Vectors and Other Viral Vectors), Type of Therapy (Gene Augmentation, Gene Editing, Gene Regulation, Oncolytic Immunotherapies and Other Therapies), Type of Gene Delivery Method (Ex Vivo Gene Delivery and In vivo Gene Delivery), Route of Administration (Intramuscular Route, Intratumoral Route, Intravenous Route, Subretinal Route and Other Routes of Administration), Geographical Regions (North America, Europe, Asia-Pacific, Latin America and Rest of the World), Leading Players and Sales Forecast: Industry Trends and Global Forecasts, Till 2035
... Virus Vectors, Lentivirus Vectors, Non-viral Vectors, Retrovirus Vectors and Other Viral Vectors), Type of Therapy (Gene Augmentation, Gene Editing, Gene Regulation, Oncolytic Immunotherapies and Other Therapies), Type of Gene Delivery Method (Ex Vivo Gene Delivery ... Read More
-
Global Drug of Abuse Testing Market (By Product Type, Sample / Test Type, Drug Type, End Users / Setting Type, Country Analysis), Regulatory Status, Recent Developments, Company Profiles - Forecast to 2032
... of abuse testing market was valued at US$ 6,973 Million in 2023, and is predicted to reach US$ 11,715 Million by 2032. The use of illicit drugs is increasing across the globe. An estimated 296 ... Read More
-
Global Syphilis Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Syphilis is one of the vital sexually transmitted infections (STIs) caused by the bacteria named, ... Read More
-
Syphilis Immunoassay Diagnostics Market (Product: Analyzer and Kits & Reagents); Technology: (Chemiluminescence Assay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), Immunochromatographic Assay /Lateral Flow Assay, Treponema pallidum latex agglutination (TPLA) and Non-treponemal Flocculation Assay - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034 Syphilis Immunoassay Diagnostics Market - Scope of Report TMR's report on the global syphilis immunoassay diagnostics market studies the past as well as the current growth ... Read More
-
Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029
... market trends is crucial for healthcare providers, investors, and industry stakeholders. This report offers a detailed analysis of the factors driving growth, including the increasing recognition of infectious diseases as a global health concern. As ... Read More
-
2024-2029 Global Syphilis Testing Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Syphilis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country ... Read More
-
2024 Global Sexually Transmitted Disease (Std) Diagnosis Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product ... Read More
-
2024 Global Sexually Transmitted Diseases Testing Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
Global Herpes Zoster Therapeutics Market 2024-2028
... period. The report on the herpes zoster therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Global Socially Stigmatized Diseases Market 2024-2028
... stigmatized diseases market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
2024-2029 Global Sexually-Transmitted Diseases (STD) Market for AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, and Trichomonas Vaginalis Tests: US, Europe, Japan - Suppli
... Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities This new report from LeadingMarketResearch.com provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles ... Read More
-
Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living with HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029
... The latent TB testing market will rise in value from estimated USD 582.5 million in 2024 to USD 773.4 million in 2029, at a CAGR of 5.8% over the forecast period. Increased funding and grants ... Read More